| Nutritional and functional assessment of haloarchaea and microalgae from the Andalusian shoreline: Promising functional foods with a high nutritional value |
|
| Isolation and Antitumoral Effect of a New Siphonochilone Derivative from African Ginger |
|
| Natural Products Derived from Marine Sponges with Antitumor Potential against Lung Cancer: A Systematic Review |
|
| A Novel Plant-Based Nutraceutical Combined with Exercise Can Revert Oxidative Status in Plasma and Liver in a Diet-Induced-Obesity Animal Model |
|
| LGR5 as a Therapeutic Target of Antibody-Functionalized Biomimetic Magnetoliposomes for Colon Cancer Therapy |
|
| Experimental Tumor Induction and Evaluation of Its Treatment in the Chicken Embryo Chorioallantoic Membrane Model: A Systematic Review |
|
| Plant-Derived Bioactive Compounds for Rhabdomyosarcoma Therapy In Vitro: A Systematic Review |
|
| Antitumor activity of bengamide ii in a panel of human and murine tumor cell lines: In vitro and in vivo determination of effectiveness against lung cancer |
|
| Improved antitumor activity through a tyramidyl maslinic acid derivative. Design and validation as drug-loaded electrospun polymeric nanofibers |
|
| Argan pulp as a novel functional ingredient with beneficial effects on multiple metabolism biomarkers |
|
| Emericellopsis maritima and Purpureocillium lilacinum Marine Fungi as a Source of Functional Fractions with Antioxidant and Antitumor Potential in Colorectal Cancer: A Preliminary Study |
|
| Telocytes in Human Embryonic Development: A Preliminary Microscopic Anatomy Study |
|
| Combining Olaparib and Ascorbic Acid on Nanoparticles to Enhance the Drug Toxic Effects in Pancreatic Cancer |
|
| Plant-Mediated Inorganic Nanoparticles for Anti-Tumor Therapy in Colorectal Cancer: A Systematic Review |
|
| Antiproliferative, Antioxidant, Chemopreventive and Antiangiogenic Potential of Chromatographic Fractions from <i>Anemonia sulcata</i> with and without Its Symbiont <i>Symbiodinium</i> in Colorectal Cancer Therapy |
|
| Evaluating Metabolite-Based Biomarkers for Early Diagnosis of Pancreatic Cancer: A Systematic Review |
|
| Cancer Stem Cells in Sarcomas: In Vitro Isolation and Role as Prognostic Markers: A Systematic Review |
|
| Serum NMR metabolomics analysis of human metastatic colorectal cancer: biomarkers and pathway analysis |
|
| Vegetal-Derived Bioactive Compounds as Multidrug Resistance Modulators in Colorectal Cancer |
|
| Preventive effects of Brassicaceae family for colon cancer prevention: A focus on in vitro studies |
|
| In vivo antitumor activity of Euphorbia lathyris ethanol extract in colon cancer models |
|
| In Vitro Efficacy of Extracts and Isolated Bioactive Compounds from Ascomycota Fungi in the Treatment of Colorectal Cancer: A Systematic Review |
|
| Antioxidant and Chemopreventive Activity of Protein Hydrolysates from Raw and Germinated Flour of Legumes with Commercial Interest in Colorectal Cancer |
|
| Active Biomolecules from Vegetable Extracts with Antitumoral Activity against Pancreas Cancer: A Systematic Review (2011–2021) |
|
| PARP1 inhibition by Olaparib reduces the lethality of pancreatic cancer cells and increases their sensitivity to Gemcitabine |
|
| Circular Sponge against miR-21 Enhances the Antitumor Activity of Doxorubicin against Breast Cancer Cells |
|
| Colon cancer therapy with calcium phosphate nanoparticles loading bioactive compounds from Euphorbia lathyris: In vitro and in vivo assay |
|
| Antibody-Functionalized Nanoformulations for Targeted Therapy of Colorectal Cancer: A Systematic Review |
|
| Bioavailability and biotransformation of linolenic acid from basil seed oil as a novel source of omega-3 fatty acids tested on a rat experimental model |
|
| Reversion of neuronal differentiation induced in human adipose-derived stem cells |
|
| The Development of the Bengamides as New Antibiotics against Drug-Resistant Bacteria |
|
| In Vivo Nutritional Assessment of the Microalga Nannochloropsis gaditana and Evaluation of the Antioxidant and Antiproliferative Capacity of Its Functional Extracts |
|
| Synthetic Circular miR-21 Sponge as Tool for Lung Cancer Treatment |
|
| Evaluation of poly (lactic-co-glycolic acid) nanoparticles to improve the therapeutic efficacy of paclitaxel in breast cancer |
|
| Electrospraying as a Technique for the Controlled Synthesis of Biocompatible PLGA@Ag<sub>2</sub>S and PLGA@Ag<sub>2</sub>S@SPION Nanocarriers with Drug Release Capability |
|
| The antitumor activity of sodium selenite alone and in combination with gemcitabine in pancreatic cancer: An in vitro and in vivo study |
|
| Identification of PARP-1 in cancer stem cells of gastrointestinal cancers: A preliminary study |
|
| Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications |
|
| In vitro evidence of the antitumor capacity of Solanaceae and Cucurbitaceae in colon cancer: A systematic review |
|
| Paclitaxel antitumor effect improvement in lung cancer and prevention of the painful neuropathy using large pegylated cationic liposomes |
|
| Antioxidant and antiproliferative potential of ethanolic extracts from Moringa oleifera, Tropaeolum tuberosum and Annona cherimola in colorrectal cancer cells. |
|
| Impact of the Epigenetically Regulated Hoxa-5 Gene in Neural Differentiation from Human Adipose-Derived Stem Cells |
|
| Circulating PTGS2, JAG1, GUCY2C and PGF mRNA in Peripheral Blood and Serum as Potential Biomarkers for Patients with Metastatic Colon Cancer |
|
| Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress |
|
| Antitumor Effect of the Ethanolic Extract from Seeds of Euphorbia lathyris in Colorectal Cancer |
|
| Anemonia sulcata and Its Symbiont Symbiodinium as a Source of Anti-Tumor and Anti-Oxidant Compounds for Colon Cancer Therapy: A Preliminary In Vitro Study |
|
| Germination improves the polyphenolic profile and functional value of mung bean (Vigna radiata L.) |
|
| Nanoparticles in Colorectal Cancer Therapy: Latest In Vivo Assays, Clinical Trials, and Patents |
|
| Biomimetic magnetoliposomes as oxaliplatin nanocarriers: In vitro study for potential application in colon cancer |
|
| Bengamide Analogues Show A Potent Antitumor Activity against Colon Cancer Cells: A Preliminary Study |
|
| Gemcitabine-loaded magnetically responsive poly(ε-caprolactone) nanoparticles against breast cancer |
|
| MMR-proficient and MMR-deficient colorectal cancer cells: 5-Fluorouracil treatment response and correlation to CD133 and MGMT expression |
|
| Nanomedicine in Pancreatic Cancer: A New Hope for Treatment |
|
| Cancer therapy based on extracellular vesicles as drug delivery vehicles |
|
| Magnetically active pNIPAM nanosystems as temperature-sensitive biocompatible structures for controlled drug delivery |
|
| Differentiation of human mesenchymal stem cells towards neuronal lineage: Clinical trials in nervous system disorders |
|
| Evaluation of Novel Doxorubicin-Loaded Magnetic Wax Nanocomposite Vehicles as Cancer Combinatorial Therapy Agents |
|
| Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics |
|
| Oxaliplatin–biomimetic magnetic nanoparticle assemblies for colon cancer-targeted chemotherapy: An in vitro study |
|
| Lipid-based nanoparticles: Application and recent advances in cancer treatment |
|
| Electrospun nanofibers: Recent applications in drug delivery and cancer therapy |
|
| An updated review of adipose derived-mesenchymal stem cells and their applications in musculoskeletal disorders |
|
| A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer |
|
| Double origin of the extensor hallucis longus muscle: a case report |
|
| Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer |
|
| The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview |
|
| The expression of MMR, CD133 and the presence of p53 wt predict the response to cabazitaxel in malignant neural tumours cell lines |
|
| Nanoformulations for glioblastoma multiforme: A new hope for treatment |
|
| Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer |
|
| DNA methylation patterns as molecular biomarkers: An overview in colorectal cancer |
|
| Latest in Vitro and in Vivo Assay, Clinical Trials and Patents in Cancer Treatment using Curcumin: A Literature Review |
|
| Formulation and in vitro evaluation of magnetoliposomes as a potential nanotool in colorectal cancer therapy |
|
| Nanoemulsion strategy for ursolic and oleanic acids isolates from plumeria obtusa improves antioxidant and cytotoxic activity in melanoma cells |
|
| Proteomic biomarkers in body fluids associated with pancreatic cancer |
|
| Nano-engineering of biomedical prednisolone liposomes: evaluation of the cytotoxic effect on human colon carcinoma cell lines |
|
| Development of biomedical 5-fluorouracil nanoplatforms for colon cancer chemotherapy: Influence of process and formulation parameters |
|
| Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(?-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study |
|
| Untargeted LC-HRMS-based metabolomics for searching new biomarkers of pancreatic ductal adenocarcinoma: A pilot study |
|
| Tripalmitin nanoparticle formulations significantly enhance paclitaxel antitumor activity against breast and lung cancer cells in vitro |
|
| Development and Characterization of Magnetite/Poly(butylcyanoacrylate) Nanoparticles for Magnetic Targeted Delivery of Cancer Drugs |
|
| Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil |
|
| Gastrointestinal stromal tumours: An actualized overview |
|
| Paclitaxel-loaded hollow-poly(4-vinylpyridine) nanoparticles enhance drug chemotherapeutic efficacy in lung and breast cancer cell lines |
|
| Last advances in nanocarriers-based drug delivery systems for colorectal cancer |
|
| Magnetic solid lipid nanoparticles in hyperthermia against colon cancer |
|
| Current status of immunotherapy treatments for pancreatic cancer |
|
| Meroxest improves the prognosis of immunocompetent C57BL/6 mice with allografts of E0771 mouse breast tumor cells |
|
| Microenvironmental modulation of decorin and lumican in temozolomide-resistant glioblastoma and neuroblastoma cancer stem-like cells |
|
| Poly(butylcyanoacrylate) and Poly(?-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer |
|
| Specific colon cancer cell cytotoxicity induced by bacteriophage E gene expression under transcriptional control of carcinoembryonic antigen promoter |
|
| Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(Butylcyanoacrylate) nanoparticles |
|
| Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(Butylcyanoacrylate) nanoparticles |
|
| Temozolomide resistance in glioblastoma cell lines: Implication of MGMT, MMR, P-glycoprotein and CD133 expression |
|
| Polystyrene nanoparticles facilitate the internalization of impermeable biomolecules in non-tumour and tumour cells from colon epithelium |
|
| Tissue Specific Promoters in Colorectal Cancer |
|
| Transcriptional profiling of peripheral blood in pancreatic adenocarcinoma patients identifies diagnostic biomarkers |
|
| Erratum: A novel double-enhanced suicide gene therapy in a colon cancer cell line mediated by gef and apoptin (BioDrugs DOI : 10.1007/s40259-013-0055-0) |
|
| Cancer stem cells and their implication in breast cancer |
|
| Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma |
|
| Novel merosesquiterpene exerts a potent antitumor activity against breast cancer cells in vitro and in vivo |
|
| ENHANCED EFFECT OF CYTOTOXIC DRUGS IN THE TREATMENT OF LUNG CELLS CANCER |
|
| IMPROVING DISASTER AWARENESS AND PREPAREDNESS AMONG FAMILIES OF CHILDREN WITH SPECIAL HEALTHCARE NEEDS |
|
| Application of nanotechnology in the treatment and diagnosis of gastrointestinal cancers: review of recent patents. |
|
| Qualitative and quantitative analyses of anatomists' research: Evaluation of multidisciplinarity and trends in scientific production |
|
| Regulatory Systems in Bone Marrow for Hematopoietic Stem/Progenitor Cells Mobilization and Homing |
|
| Modulation of multidrug resistance gene expression in peripheral blood mononuclear cells of lung cancer patients and evaluation of their clinical significance |
|
| Colon cancer therapy: Recent developments in nanomedicine to improve the efficacy of conventional chemotherapeutic drugs |
|
| Antitumor properties of natural compounds and related molecules |
|
| Nano-engineering of 5-fluorouracil-loaded magnetoliposomes for combined hyperthermia and chemotherapy against colon cancer |
|
| Four accessory (supernumerary) intrathoracic ribs: A case report |
|
| RNA interference in the treatment of colon cancer |
|
| Biocompatible gemcitabine-based nanomedicine engineered by Flow Focusing (R) for efficient antitumor activity |
|
| How is gene transfection able to improve current chemotherapy? The role of combined therapy in cancer treatment |
|
| 5-Fluorouracil-loaded poly(epsilon-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer |
|
| 5-fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer |
|
| MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy |
|
| DNA methylation plasticity of human adipose-derived stem cells in lineage commitment |
|
| Modulation of MDR1 and MRP3 Gene Expression in Lung Cancer Cells after Paclitaxel and Carboplatin Exposure |
|
| Doxorubicin-Loaded Nanoparticles: New Advances in Breast Cancer Therapy |
|
| New gene therapy strategies for cancer treatment: A review of recent patents |
|
| MDR1 gene expression in peripheral blood as a marker of treatment response in lung cancer |
|
| Drug resistance induced by paclitaxel and carboplatin plasmatic concentrations in lung cancer cell lines |
|
| Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells |
|
| Cannabinoid derivate-loaded PLGA nanocarriers for oral administration: formulation, characterization, and cytotoxicity studies |
|
| New Gene Therapy Strategies for Cancer Treatment: A Review of Recent Patents |
|
| New gene therapy strategies for cancer treatment: A review of recent patents |
|
| 5-Fluorouracil derivatives: a patent review |
|
| E phage gene transfection associated to chemotherapeutic agents increases apoptosis in lung and colon cancer cells |
|
| Synergistic antitumoral effect of combination E gene therapy and Doxorubicin in MCF-7 breast cancer cells |
|
| gef gene expression in MCF-7 breast cancer cells is associated with a better prognosis and induction of apoptosis by p53-mediated signaling pathway |
|
| Multidrug resistance and rhabdomyosarcoma (review) |
|
| Regenerative therapies in cartilage and bone: Current patents, technologies, and emerging applications |
|
| Development of patents and clinical trials on regenerative therapy: Gene therapy |
|
| Drug Resistance Induced by Plasmatic Concentrations of Paclitaxel and Carboplatin in Cancer Cell Lines |
|
| Drug resistance induced by plasmatic concentrations of paclitaxel and carboplatin |
|
| Nanomedicine: Application Areas and Development Prospects |
|
| TRANSFECTION OF THE GENE E AND LATER APPLICATION OF CYTOTOXIC DRUGS IN THE TREATMENT OF COLON CELLS CANCER |
|
| Promotion of human adipose-derived stem cell proliferation mediated by exogenous nucleosides |
|
| Capsular origin of the long head of the biceps brachii tendon: A clinical case |
|
| Gef gene therapy enhances the therapeutic efficacy of doxorubicin to combat growth of MCF-7 breast cancer cells |
|
| Differentiation of intestinal epithelial cells mediated by cell confluence and/or exogenous nucleoside supplementation |
|
| E phage gene transfection enhances sensitivity of lung and colon cancer cells to chemotherapeutic agents |
|
| ASSOCIATION BETWEEN MDR1 EXPRESSION LEVELS AND CHEMOTHERAPY RESPONSE IN NON SMALL CELL LUNG CANCER (NSCLC) PATIENTS |
|
| Release of muscle α-actin into serum after intensive exercise |
|
| Mdr1 gene expression as a marker of treatment response in non-small cell lung cancer (NSCLC) |
|
| Regression of established subcutaneous B16-F10 murine melanoma tumors after gef gene therapy associated with the mitochondrial apoptotic pathway |
|
| The cytotoxic activity of the phage E protein suppress the growth of Murine B16 Melanomas in vitro and in vivo |
|
| The cytotoxic activity of the phage E protein suppress the growth of murine B16 melanomas in vitro and in vivo |
|
| Combined therapy using suicide gef gene and paclitaxel enhances growth inhibition of multicellular tumour spheroids of A-549 human lung cancer cells |
|
| Tumour malignancy loss and cell differentiation are associated with induction of gef gene in human melanoma cells |
|
| Pedagogic evaluation of anatomical teaching for a medical and surgical degree at the University of Granada |
|
| Role of the organization of subjects and the educational resources used in their teaching in the Anatomy education-learning process |
|
| Methodology in the European higher education area for the Anatomy learning in the Health Sciences |
|
| Anatomy teaching to physiotherapy students: Preliminary study in the European higher education area setting |
|
| GABA(A)R lateral mobility and localization |
|
| Anatomy instruction in physiotherapy students: a preliminary study in the context of the European higher education area |
|
| Construction of a new recombinant adenovirus: possible uses in gene therapy |
|
| Learning and teaching human anatomy through virtual reality: functional and clinical study of the knee joint |
|
| Differentiation: An encouraging approach to anticancer therapy |
|
| Induction of drug resistance in embryonal rhabdomyosarcoma treated with conventional chemotherapy is associated with HLA class I increase |
|
| Modulation of Ki-67 expression and morphological changes induced by GEF gene in MCF-7 human breast cancer cells |
|
| Non-viral and viral vectors for gene therapy |
|
| Cancer gene therapy: Strategies and clinical trials |
|
| Contractile regulatory proteins tropomyosin and troponin-T as indicators of the modulatory role of retinoic acid |
|
| Modulation of HLA class I expression in multidrug-resistant human rhabdomyosarcoma cells |
|
| Inhibition of growth and induction of apoptosis in human breast cancer by transfection of gef gene |
|
| Transfection of MS-36 melanoma cells with gef gene inhibits proliferation and induces modulation of the cell cycle |
|
| Reverse transcriptase-polymerase chain reaction detection of circulating tumor cells in patients with melanoma: Correlation with clinical stage, tumor thickness and histological type |
|
| Development of chick cardiomyocytes: Modulation of intermediate filaments by basic fibroblast and platelet-derived growth factors |
|
| Modulation of myogenic differentiation in a human rhabdomyosarcoma cell line by a new derivative of 5-fluorouracil (QF-3602) |
|
| Modulation of α-actin and α-actinin proteins in cardiomyocytes by retinoic acid during development |
|
| Multidrug resistance phenotype in the RMS-GR human rhabdomyosarcoma cell line obtained after polychemotherapy |
|
| GR-891: A novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells |
|
| Optimization of the tyrosinase mRNA probe to detect circulating melanocytes with reverse transcription and polymerase chain reaction. |
|
| Characterization of a new human embryonal rhabdomyosarcoma cell line, RMS-GR |
|
| Therapeutic differentiation in a human rhabdomyosarcoma cell line selected for resistance to actinomycin D |
|
| Low sample volume causes differentiation in human rhabdomyosarcoma cell line RD subjected to electroporation (vol 42, pg 1219, 1996) |
|
| Clinical significance of antiheart antibodies after myocardial infarction |
|
| Actinomycin D treatment leads to differentiation and inhibits proliferation in rhabdomyosarcoma cells |
|
| Chemical modifications on the acyclic moiety of 3-(2-hydroxyethoxy)-1-alkoxypropyl nucleobases. 2. Differentiation and growth inhibition in rhabdomyosarcoma cells after exposure to a novel 5-fluorouracil acyclonucleoside |
|
| Morphometric study of the great arterial trunks and their branches in the human fetal heart with perimembranous ventricular septal defects |
|
| Low sample volume causes differentiation in human rhabdomyosarcoma cell line RD subjected to electroporation. |
|
| Inverse expression of mdr 1 and c-myc genes in a rhabdomyosarcoma cell line resistant to actinomycin D |
|
| Detection of circulating alpha-actinin in non-insulin-dependent diabetics with autonomic dysfunction |
|
| Low concentrations of actinomycin D potentially cause therapeutic differentiation in human rhabdomyosarcoma cell line RD |
|
| Modulation of cardiac intermediate filament proteins in the chick heart by fibric acid derivatives |
|
| Basic fibroblast and platelet-derived growth factors as modulators of actin and α-actinin in chick myocardiocytes during development |
|
| Circulating α-actin in non-insulin-dependent diabetics with autonomic dysfunction |
|
| Differentiation in the RD rhabdomyosarcoma cell line after electroporation |
|
| Swine hearts: quantitative anatomy of the right ventricle. |
|
| Differentiation of a human rhabdomyosarcoma cell line after antineoplastic drug treatment |
|
| Creatine kinase isoenzymes as markers of differentiation in rhabdomyosarcoma cells in culture |
|
| Modulation of contractile protein troponin-T in chick myocardial cells by basic fibroblast growth factor and platelet-derived growth factor during development |
|
| Modulation of contractile protein troponin-T in chick myocardial cells by catecholamines during development. |
|
| Production and characterization of a new monoclonal antibody, GR-ICOR-2, recognizing sarcomeric actin: Analysis of the expression in the developing chick heart |
|
| Modulation of contractile proteins in embryonic and fetal chick cardiac cells by phorbol ester, gamma-interferon, 5-azacytidine and diacylglycerols |
|
| Influence of dimethyl sulphoxide on intermediate filament proteins in human rhabdomyosarcoma cell lines: modulation at subcellular level |
|
| ACTINOMYCIN-D CAUSES MULTIDRUG-RESISTANCE AND DIFFERENTIATION IN A HUMAN RHABDOMYOSARCOMA CELL-LINE |
|
| The swine heart: the papillo-tendino-valvular system of the right ventricle | Corazón cerdo: sistema papilo-tendino-valvular del ventrículo derecho. |
|
| PAPILLO-TENDINO-VALVULAR SYSTEM OF THE RIGHT VENTRICLE OF SWINE HEARTS |
|
| Expression of epidermal growth factor receptor in chick embryo myocardiocytes: relation with desmin expression during cardiac development |
|
| Actin, tropomyosin and alpha-actinin as markers of differentiation in human rhabdomyosarcoma cell lines induced with dimethyl sulfoxide. |
|
| Production of a new monoclonal antibody recognizing alpha-actinin: analysis of the changes in subcellular expression in the developing chick heart. |
|
| Changes in subcellular accumulation of contractile proteins in myocardiocyte cultures: Effects of fibric acid derivatives |
|
| Circulating α-actin in angina pectoris |
|
